Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02329652 · ClinicalTrials.gov registry record · NA
Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
A NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by Anne Bryden.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02329652: Recruiting NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by Anne Bryden.
NCT02329652 is a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical that is actively recruiting participants, run by Anne Bryden. The registered enrollment target is 30 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02329652, a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, is actively recruiting participants, sponsored by Anne Bryden.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to evaluate the use of a fully implanted device for providing hand function, reach, and trunk function to individuals with cervical spinal cord injury. Funding Sources: FDA OOPD NIH NINDS
Primary Outcome
Evaluation of ability to perform activities of daily living when using the neuroprosthesis compared to ability when the neuroprosthesis is turned off.
Conditions Studied
Interventions
- DEVICE Networked Neuroprosthetic System for Grasp and Trunk
Study Locations (1)
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2031-12-31 |
| Phase | NA |
What NCT02329652 shows while recruiting
NCT02329652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower).
The record links to 5 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Networked Neuroprosthetic System for Grasp and Trunk is the first listed.
NCT02329652 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02329652 about?
NCT02329652 is a clinical study titled "Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury". This study is to evaluate the use of a fully implanted device for providing hand function, reach, and trunk function to individuals with cervical spinal cord injury. Funding Sources: FDA OOPD NIH NINDS
What is the current status of trial NCT02329652?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2014-12-01. Estimated completion is 2031-12-31.
What conditions does trial NCT02329652 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Injury Cervical, Spinal Cord Injury at C5-C7 Level, Spinal Cord Injury at C5-C7 Level With Complete Lesion, Spinal Cord Injury at C5-C7 Level With Incomplete Lesion.
What interventions are being tested in trial NCT02329652?
The interventions under investigation include: Networked Neuroprosthetic System for Grasp and Trunk (DEVICE).
Who is sponsoring clinical trial NCT02329652?
This trial is sponsored by Anne Bryden, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02329652 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02329652's enrollment target sits among peer trials
30 90th of 202 higher than 99 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy